About St James's University Hospital - Haematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Celgene
1
Clinical Trials at St James's University Hospital - Haematology
During the past decade, St James's University Hospital - Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
2002-04-01
2005-07-01
Completed
600
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
2003-06-01
2007-02-01
Completed
215
Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
2004-09-01
2008-02-01
Terminated
88
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
2011-03-01
2014-07-31
Completed
74
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-12-27
2024-12-31
Active, not recruiting
438
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St James's University Hospital - Haematology" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Celgene" with 1 trials
sponsored, "Celgene Corporation" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at St James's University Hospital - Haematology
According to Clinical.Site data, the most researched conditions in "St James's University Hospital - Haematology" are
"Multiple Myeloma" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "St James's University Hospital - Haematology" in a lesser frequency.
Clinical Trials Intervention Types at St James's University Hospital - Haematology
Most popular intervention types in "St James's University Hospital - Haematology" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "CC-5013" (1 trials), "Chlorambucil" (1 trials), "R-etodolac + chlorambucil" (1 trials) and "bortezomib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St James's University Hospital - Haematology
The vast majority of trials in "St James's University Hospital - Haematology" are
6 trials for "All" genders.
Clinical Trials Status at St James's University Hospital - Haematology
Currently, there are NaN active trials in "St James's University Hospital - Haematology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in St James's University Hospital - Haematology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St James's University Hospital - Haematology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".